McKesson (MCK) Earns “Hold” Rating from Mizuho

McKesson (NYSE:MCK)‘s stock had its “hold” rating reaffirmed by investment analysts at Mizuho in a research report issued to clients and investors on Sunday. They presently have a $133.00 price target on the stock. Mizuho’s target price points to a potential upside of 7.12% from the stock’s previous close.

A number of other equities research analysts have also recently commented on the stock. Morgan Stanley reduced their price target on shares of McKesson from $175.00 to $142.00 and set an “equal weight” rating for the company in a report on Tuesday, July 3rd. Citigroup reduced their price objective on shares of McKesson from $160.00 to $2.86 and set a “buy” rating for the company in a report on Friday, July 20th. Standpoint Research upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Tuesday, July 10th. Jefferies Financial Group reiterated a “buy” rating and set a $160.00 price objective on shares of McKesson in a report on Friday, July 27th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of McKesson from $181.00 to $160.00 and set an “overweight” rating for the company in a report on Friday, July 27th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company’s stock. McKesson currently has an average rating of “Hold” and an average price target of $154.30.

NYSE:MCK traded up $1.02 during trading hours on Friday, reaching $124.16. The company had a trading volume of 6,229 shares, compared to its average volume of 1,797,162. The company has a current ratio of 1.00, a quick ratio of 0.57 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $24.60 billion, a price-to-earnings ratio of 9.84, a PEG ratio of 1.30 and a beta of 1.22. McKesson has a twelve month low of $122.63 and a twelve month high of $178.86.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, July 26th. The company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.89 by $0.01. The business had revenue of $52.61 billion during the quarter, compared to analysts’ expectations of $52.91 billion. McKesson had a negative net margin of 0.18% and a positive return on equity of 25.19%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the company posted $2.47 earnings per share. equities analysts predict that McKesson will post 13.33 earnings per share for the current fiscal year.

In related news, SVP Erin M. Lampert sold 868 shares of the business’s stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $142.00, for a total transaction of $123,256.00. Following the transaction, the senior vice president now directly owns 64 shares in the company, valued at $9,088. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.87% of the stock is currently owned by insiders.

A number of institutional investors have recently added to or reduced their stakes in the stock. Boston Partners raised its position in McKesson by 54.5% in the second quarter. Boston Partners now owns 6,237,042 shares of the company’s stock worth $832,021,000 after acquiring an additional 2,200,669 shares during the period. Pzena Investment Management LLC raised its position in McKesson by 7.6% in the second quarter. Pzena Investment Management LLC now owns 2,836,710 shares of the company’s stock worth $378,417,000 after acquiring an additional 201,062 shares during the period. Kiltearn Partners LLP raised its position in McKesson by 6.3% in the first quarter. Kiltearn Partners LLP now owns 1,914,898 shares of the company’s stock worth $269,350,000 after acquiring an additional 112,800 shares during the period. Wells Fargo & Company MN raised its position in McKesson by 13.3% in the first quarter. Wells Fargo & Company MN now owns 1,859,883 shares of the company’s stock worth $262,000,000 after acquiring an additional 218,530 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in McKesson by 0.6% in the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,663,100 shares of the company’s stock worth $234,281,000 after acquiring an additional 9,300 shares during the period. Institutional investors and hedge funds own 91.76% of the company’s stock.

About McKesson

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

See Also: Price to Earnings Ratio (PE), For Valuing Stocks

Analyst Recommendations for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit